日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

First-line treatment of anti-EGFR monoclonal antibody cetuximab β plus FOLFIRI versus FOLFIRI alone in Chinese patients with RAS/BRAF wild-type metastatic colorectal cancer: a randomized, phase 3 trial

在中国RAS/BRAF野生型转移性结直肠癌患者中,一线治疗方案为抗EGFR单克隆抗体西妥昔单抗β联合FOLFIRI方案与单用FOLFIRI方案的比较:一项随机、3期临床试验

Shi, Yuankai; Ba, Yi; Wang, Junye; Xiong, Jianping; Gu, Kangsheng; Chen, Yigui; Zheng, Zhendong; Wang, Zishu; Guo, Weijian; Cheng, Ying; Yin, Xianli; Liu, Yunpeng; Bai, Yuxian; Li, Enxiao; Li, Qi; Zhu, Liangjun; Li, Wei; Jiang, Da; He, Jingdong; Chen, Jiansi; Sun, Jianguo; Hou, Sheng

CLDN18.2-targeting antibody-drug conjugate IBI343 in advanced gastric or gastroesophageal junction adenocarcinoma: a phase 1 trial

CLDN18.2靶向抗体药物偶联物IBI343治疗晚期胃癌或胃食管交界处腺癌:一项I期试验

Liu, Jia; Yang, Jianwei; Sun, Yuping; Gong, Jifang; Yue, Jinbo; Pan, Yueyin; Sun, Meili; Song, Rongfeng; Xiao, Xiuying; Tazbirkova, Andrea; Ruan, Jian; Liu, Zhenyang; Liu, Zimin; Li, Zhihua; Sheng, Lili; Qin, Yanru; Ying, Jieer; Yu, Xianjun; Zhang, Jian; Mou, Yiping; Lu, Chuangxin; Chen, Ping; Li, Suyi; Li, Jie; Qu, Xiujuan; Deng, Ting; Du, Juan; Zhou, Aiping; Li, Enxiao; Yuan, Xianglin; Liang, Xinjun; Yu, Weiming; Morris, Michelle; Luo, Yang; Zhao, Xin; Guo, Yingmei; Zhou, Hui; Shen, Lin

Retrospective analysis of disease characteristics and treatment patterns among patients with esophageal cancer across 14 surgically represented centers

对14个开展手术的中心中食管癌患者的疾病特征和治疗模式进行回顾性分析

Lu, Zhihao; Geng, Mingfei; Han, Yongtao; Cao, Jianzhong; Wang, Jun; Liu, Tianshu; Yuan, Xianglin; Meng, Xue; Zhang, Yanqiao; Zhao, Rong; Wan, Lixin; Li, Enxiao; Wang, Wenran; Li, Zhijie; Shi, Danfeng; Qian, Jing; Shi, Si; Dong, Fengshi; Shen, Lin

A multi-omics prognostic model of cuproptosis affects the prognosis of stomach adenocarcinoma

铜沉积症的多组学预后模型影响胃腺癌的预后

Wu, Yinying; Fan, Yangwei; Dong, Xuyuan; Dong, Danfeng; Shi, Yu; Wang, Meichen; Wang, Jia; Yang, Yuqian; Yang, Nan; Ou, Fengyun; Li, Enxiao

Baseline radiologic features as predictors of efficacy in patients with pancreatic neuroendocrine tumors with liver metastases receiving surufatinib

基线放射学特征作为预测接受舒鲁法替尼治疗的伴肝转移的胰腺神经内分泌肿瘤患者疗效的指标

Zhang, Jianwei; Zhu, Haibin; Shen, Lin; Li, Jie; Zhang, Xiaoyan; Bai, Chunmei; Zhou, Zhiwei; Yu, Xianrui; Li, Zhiping; Li, Enxiao; Yuan, Xianglin; Lou, Wenhui; Chi, Yihebali; Xu, Nong; Yin, Yongmei; Bai, Yuxian; Zhang, Tao; Xiu, Dianrong; Chen, Jia; Qin, Shukui; Wang, Xiuwen; Yang, Yujie; Shi, Haoyun; Luo, Xian; Fan, Songhua; Su, Weiguo; Lu, Ming; Xu, Jianming

Loss of chromosome 9p21 is associated with a poor prognosis in adenosquamous carcinoma of the pancreas

9p21染色体缺失与胰腺腺鳞癌预后不良相关。

Jiang, Yina; Wu, Yinying; Zhang, Liwen; Wang, Yan; Xu, Guiping; Deng, Yuan; Han, Liang; Li, Enxiao; Ma, Qingyong; Xu, Mian; Wu, Zheng; Wang, Zheng

A Randomized Phase III Study of Anlotinib Versus Bevacizumab in Combination With CAPEOX as First-Line Therapy for RAS/BRAF Wild-Type Metastatic Colorectal Cancer: A Clinical Trial Protocol

安罗替尼与贝伐珠单抗联合CAPEOX方案作为RAS/BRAF野生型转移性结直肠癌一线治疗的随机III期研究:临床试验方案

He, Jinjie; Liu, Yue; Liu, Chengcheng; Hu, Hanguang; Sun, Lifeng; Xu, Dong; Li, Jun; Wang, Junye; Chen, Xiaobing; Lin, Rongbo; Jiang, Yi; Zhang, Yanqiao; Zhang, Weisheng; Cheng, Ying; Wu, Xiaohong; Fang, Mingzhi; Li, Enxiao; Xu, Ye; Chen, Ye; Li, Jiayi; Cui, Yanyan; Pan, Zhanyu; Zhang, Songnan; Yuan, Ying; Ding, Kefeng

Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of pancreatic cancer

中国临床肿瘤学会(CSCO):胰腺癌诊疗临床指南

Cui, Jiujie; Jiao, Feng; Li, Qi; Wang, Zheng; Fu, Deliang; Liang, Jun; Liang, Houjie; Xia, Tingyi; Zhang, Tao; Zhang, Yang; Dai, Guanghai; Zhang, Zhihong; Wang, Jian; Bai, Yongrui; Bai, Yuxian; Bi, Feng; Chen, Donghui; Cao, Dan; Chen, Jie; Fang, Weijia; Gao, Yong; Guo, Jianwei; Hao, Jihui; Hua, Haiqing; Huang, Xinyu; Liu, Wenchao; Liu, Xiufeng; Li, Da; Li, Ji; Li, Enxiao; Li, Zhiwei; Pan, Hongming; Shen, Lin; Sun, Yongwei; Tao, Min; Wang, Chengfeng; Wang, Fenghua; Xiong, Jianping; Zhang, Taiping; Zhang, Xuebin; Zhan, Xianbao; Zheng, Leizhen; Ren, Gang; Zhang, Tingting; Zhou, Jun; Ma, Qingyong; Qin, Shukui; Hao, Chunyi; Wang, Liwei

Necrolytic migratory erythema is an important visual cutaneous clue of glucagonoma

坏死性游走性红斑是胰高血糖素瘤的重要皮肤视觉线索。

Li, Wei; Yang, Xue; Deng, Yuan; Jiang, Yina; Xu, Guiping; Li, Enxiao; Wu, Yinying; Ren, Juan; Ma, Zhenhua; Dong, Shunbin; Han, Liang; Ma, Qingyong; Wu, Zheng; Wang, Zheng

Efficacy and safety of a novel anti-HER2 therapeutic antibody RC48 in patients with HER2-overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single-arm phase II study

一项单臂II期研究评估了新型抗HER2治疗性抗体RC48在HER2过表达的局部晚期或转移性胃癌或胃食管交界处癌患者中的疗效和安全性。

Peng, Zhi; Liu, Tianshu; Wei, Jia; Wang, Airong; He, Yifu; Yang, Liuzhong; Zhang, Xizhi; Fan, Nanfeng; Luo, Suxia; Li, Zhen; Gu, Kangsheng; Lu, Jianwei; Xu, Jianming; Fan, Qingxia; Xu, Ruihua; Zhang, Liangming; Li, Enxiao; Sun, Yuping; Yu, Guohua; Bai, Chunmei; Liu, Yong; Zeng, Jiangzheng; Ying, Jieer; Liang, Xinjun; Xu, Nong; Gao, Chao; Shu, Yongqian; Ma, Dong; Dai, Guanghai; Li, Shengmian; Deng, Ting; Cui, Yuehong; Fang, Jianmin; Ba, Yi; Shen, Lin